
GSK SiranBio Deal: SA-030 siRNA Cardiometabolic Strategy
Examine the May 2026 GSK-SiranBio licensing deal for SA-030. Learn how this ALK7-targeting siRNA advances GSK's cardiometabolic and oligonucleotide strategy.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

Examine the May 2026 GSK-SiranBio licensing deal for SA-030. Learn how this ALK7-targeting siRNA advances GSK's cardiometabolic and oligonucleotide strategy.
© 2026 IntuitionLabs. All rights reserved.